H. Lundbeck A/S has closed a deal for Chelsea Therapeutics International Ltd.

Chelsea, headquartered in Deerfield, Ill., develops therapy products, including Northera. The medicine, which treats lightheadedness in patients with low blood pressure, was  approved by the U.S. Food and Drug Administration earlier this year.

Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.